New study tests safer, faster fertility option for PCOS patients
NCT ID NCT07171970
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times
Summary
This study compares two fertility treatments for women with polycystic ovary syndrome (PCOS): a simpler in vitro maturation (IVM) method with fresh embryo transfer versus standard in vitro fertilization (IVF) with frozen embryo transfer. The goal is to see which approach leads to more live births while reducing risks like ovarian hyperstimulation syndrome. About 600 women will take part, and the results could help doctors choose the best, safest option for PCOS patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME (PCOS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IVFMD - My Duc Hospital
RECRUITINGHo Chi Minh City, Vietnam
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
estradiol valerate, progesterone, dydrogesterone, follicle-stimulating hormone (FSH)
What this could lead to
If successful, this could offer women with PCOS a simpler, safer fertility treatment that avoids the risk of ovarian hyperstimulation syndrome and reduces time to pregnancy.
What could go wrong
This is a single-center trial, and results may not apply to all clinics. The IVM approach may have lower success rates than IVF, and fresh transfer could increase cycle cancellation risk.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.